AAAAAA
Results:
1-7
|
Results: 7
Authors:
Larousse, C
Veyrac, G
Citation: C. Larousse et G. Veyrac, Clinical data with COX-1 and COX-2 inhibitors: what possible alerts in pharmacovigilance?, THERAPIE, 55(1), 2000, pp. 21-28
Authors:
Ortega, A
Pineau, A
Boniffay, J
Benois-Pineau, J
Autret, JP
Larousse, C
Citation: A. Ortega et al., Application of the CD-ROM 'Tox-Didact' for the teaching of toxicology and pharmacology, THERAPIE, 55(1), 2000, pp. 203-210
Authors:
Chiffoleau, A
Yatim, D
Garrec, F
Veyrac, G
Raoult, P
Larousse, C
Bourin, M
Citation: A. Chiffoleau et al., Warning! One buflomedil may hide another one!, THERAPIE, 55(1), 2000, pp. 221-223
Authors:
Baudot, S
Milpied-Homsi, B
Andres, P
Poirier, Y
Larousse, C
Citation: S. Baudot et al., Lansoprazole hypersensitivity syndrom, THERAPIE, 54(4), 1999, pp. 491-493
Authors:
Veyrac, G
Chiffoleau, A
Cellerin, L
Larousse, C
Bourin, M
Citation: G. Veyrac et al., Latanprost (XALATAN (R)) and systemic respiratory side effect? A case report, THERAPIE, 54(4), 1999, pp. 494-496
Authors:
Baudot, S
Milpied-Homsi, B
Jumbo, O
Larousse, C
Citation: S. Baudot et al., Oxicam hypersensibility syndrome, THERAPIE, 53(6), 1998, pp. 595-596
Authors:
Imbs, JL
Castot, A
Begaud, B
Larousse, C
Blayac, JP
Alexandre, JM
Citation: Jl. Imbs et al., Pharmacovigilance in France, B ACA N MED, 182(7), 1998, pp. 1383-1393
Risultati:
1-7
|